Clinical Trial Update: Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery [Phase 2]

View source ↗

Summary

Phase II trial exploring a multimodal approach (gene therapy & androgen deprivation therapy, radiotherapy, and surgery) for high-risk prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: High-risk Prostate Cancer, Prostate Cancer | Phase 2 | Status: UNKNOWN